More on NPCE

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+19.2% Growth)
- Ratings (9.0 Score)

Upcoming Events

- Earnings (8/6/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

NeuroPace (NQ:NPCE)
Delayed: 15.63 +0.47 (3.10%)
Prev. Close $15.16  
Open$15.52 
52 Wk High$ 
52 Wk Low$ 
Day High$15.65 
Day Low$15.14 
P/E N/A  
EPS$ 
Volume168,471 

Friends, Peers and Foes (?): RIGL, AVR, AXGN, CERS, CVRX (more...)

Jun 8, 2026 04:54 PM Form 8-K NeuroPace Inc For: Jun 05
Jun 5, 2026 05:13 PM Form 4 NeuroPace Inc For: Jun 05 Filed by: Huennekens R Scott
Jun 5, 2026 05:11 PM Form 4 NeuroPace Inc For: Jun 05 Filed by: Fischer Frank M
Jun 5, 2026 05:11 PM Form 4 NeuroPace Inc For: Jun 05 Filed by: Geiger Uri
Jun 5, 2026 05:10 PM Form 4 NeuroPace Inc For: Jun 05 Filed by: Kumar Rakhi
Jun 5, 2026 05:10 PM Form 4 NeuroPace Inc For: Jun 05 Filed by: Ryan Renee
Jun 5, 2026 05:09 PM Form 4 NeuroPace Inc For: Jun 05 Filed by: Andrade Lisa
Jun 4, 2026 04:03 PM Form 4 NeuroPace Inc For: Jun 03 Filed by: Becker Joel
May 29, 2026 08:05 AM NeuroPace to Highlight Expanding Role of Responsive Neuromodulation at the 2026 American Society for Stereotactic and Functional Neurosurgery (ASSFN) Meeting
May 29, 2026 08:00 AM NeuroPace receives FDA approval for AI-driven epilepsy care tool
View All Articles

Entities mentioned with NPCE

View All Entities